SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-21-000095
Filing Date
2021-11-05
Accepted
2021-11-05 16:11:59
Documents
92
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20210930.htm   iXBRL 10-Q 1726075
2 EX-10.1 supn-2021930x10qxex101.htm EX-10.1 49782
3 EX-31.1 supn-20210930x10qxex311.htm EX-31.1 9759
4 EX-31.2 supn-20210930x10qxex312.htm EX-31.2 10093
5 EX-32.1 supn-20210930x10qxex321.htm EX-32.1 5005
6 EX-32.2 supn-20210930x10qxex322.htm EX-32.2 5026
12 image_0.jpg GRAPHIC 4516089
  Complete submission text file 0001356576-21-000095.txt   14743145

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20210930.xsd EX-101.SCH 53624
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20210930_cal.xml EX-101.CAL 100397
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20210930_def.xml EX-101.DEF 313609
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20210930_lab.xml EX-101.LAB 694091
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20210930_pre.xml EX-101.PRE 493997
13 EXTRACTED XBRL INSTANCE DOCUMENT supn-20210930_htm.xml XML 1515480
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 211384634
SIC: 2834 Pharmaceutical Preparations